- Home
- LEDS vs ALLR Comparison
LEDS vs ALLR Comparison
Compare LEDS & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- ALLR
- Stock Information
- Founded
- LEDS 2005
- ALLR 2004
- Country
- LEDS Taiwan
- ALLR United States
- Employees
- LEDS N/A
- ALLR N/A
- Industry
- LEDS Semiconductors
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- ALLR Health Care
- Exchange
- LEDS Nasdaq
- ALLR Nasdaq
- Market Cap
- LEDS 16.1M
- ALLR 15.8M
- IPO Year
- LEDS 2010
- ALLR N/A
- Fundamental
- Price
- LEDS $2.46
- ALLR $1.71
- Analyst Decision
- LEDS
- ALLR Strong Buy
- Analyst Count
- LEDS 0
- ALLR 1
- Target Price
- LEDS N/A
- ALLR $9.25
- AVG Volume (30 Days)
- LEDS 79.8K
- ALLR 641.5K
- Earning Date
- LEDS 11-26-2025
- ALLR 11-13-2025
- Dividend Yield
- LEDS N/A
- ALLR N/A
- EPS Growth
- LEDS N/A
- ALLR N/A
- EPS
- LEDS N/A
- ALLR N/A
- Revenue
- LEDS $31,108,000.00
- ALLR N/A
- Revenue This Year
- LEDS N/A
- ALLR N/A
- Revenue Next Year
- LEDS N/A
- ALLR N/A
- P/E Ratio
- LEDS N/A
- ALLR N/A
- Revenue Growth
- LEDS 485.62
- ALLR N/A
- 52 Week Low
- LEDS $1.09
- ALLR $0.61
- 52 Week High
- LEDS $3.16
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- LEDS 68.65
- ALLR 58.30
- Support Level
- LEDS $2.20
- ALLR $1.54
- Resistance Level
- LEDS $2.64
- ALLR $1.77
- Average True Range (ATR)
- LEDS 0.18
- ALLR 0.12
- MACD
- LEDS 0.04
- ALLR -0.01
- Stochastic Oscillator
- LEDS 85.22
- ALLR 66.67
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.